Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route

NCT02082379 is registered in ClinicalTrials.gov with Arkansas Children's Hospital Research Institute as lead sponsor.

NCT NCT02082379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route
Lead sponsor
Arkansas Children's Hospital Research Institute
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
February 28, 2015
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interface acceptance during delivery of aerosol medicine to an infant or child